188 related articles for article (PubMed ID: 18486283)
1. Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.
Florese RH; Wiseman RW; Venzon D; Karl JA; Demberg T; Larsen K; Flanary L; Kalyanaraman VS; Pal R; Titti F; Patterson LJ; Heath MJ; O'Connor DH; Cafaro A; Ensoli B; Robert-Guroff M
Vaccine; 2008 Jun; 26(26):3312-21. PubMed ID: 18486283
[TBL] [Abstract][Full Text] [Related]
2. Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.
Cafaro A; Bellino S; Titti F; Maggiorella MT; Sernicola L; Wiseman RW; Venzon D; Karl JA; O'Connor D; Monini P; Robert-Guroff M; Ensoli B
J Virol; 2010 Sep; 84(17):8953-8. PubMed ID: 20554774
[TBL] [Abstract][Full Text] [Related]
3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
4. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
[TBL] [Abstract][Full Text] [Related]
5. Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy.
Borsetti A; Maggiorella MT; Sernicola L; Bellino S; Ferrantelli F; Belli R; Fulgenzi D; Mee ET; Rose NJ; Cafaro A; Ensoli B; Titti F
Tissue Antigens; 2012 Jul; 80(1):36-45. PubMed ID: 22494179
[TBL] [Abstract][Full Text] [Related]
6. Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.
Florese RH; Demberg T; Xiao P; Kuller L; Larsen K; Summers LE; Venzon D; Cafaro A; Ensoli B; Robert-Guroff M
J Immunol; 2009 Mar; 182(6):3718-27. PubMed ID: 19265150
[TBL] [Abstract][Full Text] [Related]
7. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.
Cafaro A; Caputo A; Maggiorella MT; Baroncelli S; Fracasso C; Pace M; Borsetti A; Sernicola L; Negri DR; Ten Haaft P; Betti M; Michelini Z; Macchia I; Fanales-Belasio E; Belli R; Corrias F; Buttò S; Verani P; Titti F; Ensoli B
J Med Primatol; 2000 Aug; 29(3-4):193-208. PubMed ID: 11085582
[TBL] [Abstract][Full Text] [Related]
8. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M
DNA Cell Biol; 2002 Sep; 21(9):653-8. PubMed ID: 12396607
[TBL] [Abstract][Full Text] [Related]
9. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.
Silvera P; Richardson MW; Greenhouse J; Yalley-Ogunro J; Shaw N; Mirchandani J; Khalili K; Zagury JF; Lewis MG; Rappaport J
J Virol; 2002 Apr; 76(8):3800-9. PubMed ID: 11907220
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.
Reimann KA; Parker RA; Seaman MS; Beaudry K; Beddall M; Peterson L; Williams KC; Veazey RS; Montefiori DC; Mascola JR; Nabel GJ; Letvin NL
J Virol; 2005 Jul; 79(14):8878-85. PubMed ID: 15994781
[TBL] [Abstract][Full Text] [Related]
11. Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques.
Mee ET; Berry N; Ham C; Aubertin A; Lines J; Hall J; Stebbings R; Page M; Almond N; Rose NJ
Tissue Antigens; 2010 Sep; 76(3):223-9. PubMed ID: 20403147
[TBL] [Abstract][Full Text] [Related]
12. Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243).
Borsetti A; Baroncelli S; Maggiorella MT; Moretti S; Fanales-Belasio E; Sernicola L; Tripiciano A; Macchia I; Michelini Z; Belli R; Farcomeni S; Pavone-Cossut MR; Negri D; Caputo A; Bellino S; Butto S; Titti F; Cafaro A; Ensoli B
Viral Immunol; 2009 Apr; 22(2):117-24. PubMed ID: 19326998
[TBL] [Abstract][Full Text] [Related]
13. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
[TBL] [Abstract][Full Text] [Related]
14. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques.
Campbell KJ; Detmer AM; Karl JA; Wiseman RW; Blasky AJ; Hughes AL; Bimber BN; O'Connor SL; O'Connor DH
Immunogenetics; 2009 Mar; 61(3):177-87. PubMed ID: 19107381
[TBL] [Abstract][Full Text] [Related]
16. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.
Ridolfi B; Genovese D; Argentini C; Maggiorella MT; Sernicola L; Buttò S; Titti F; Borsetti A; Ensoli B
Virus Genes; 2008 Feb; 36(1):105-15. PubMed ID: 18049888
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques.
Yang GB; Wang Y; Babaahmady K; Schøller J; Rahman D; Bunnik E; Spallek R; Zong CM; Duan JZ; Qin C; Jiang H; Singh M; Vaughan R; Bergmeier LA; Schuitemaker H; Shao Y; Lehner T
J Gen Virol; 2012 Jul; 93(Pt 7):1506-1518. PubMed ID: 22492918
[TBL] [Abstract][Full Text] [Related]
18. Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
Patterson LJ; Beal J; Demberg T; Florese RH; Malkevich N; Venzon D; Aldrich K; Richardson E; Kalyanaraman VS; Kalisz I; Lee EM; Montefiori DC; Robey FA; Robert-Guroff M
Virology; 2008 May; 374(2):322-37. PubMed ID: 18252262
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
20. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
